Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 352 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer Patients

for
Ovarian Cancer
Location: Quebec, Montreal, Toronto, Edmonton, Vancouver,
Sponsor: University College, London

Sex: Female

Age: 18+

Code: NCT03278717

Phase3, Recruiting

Prehabilitation for Ovarian Cancer Patients

for
Prehabilitation, Exercise, Frailty, Ovarian Cancer,
Location: Halifax
Sponsor: Nova Scotia Health Authority

Sex: Female

Age: 18+

Code: NCT05364879

Recruiting

Spanish Decision Tool for Ovarian Cancer Maintenance Therapy

for
Ovarian Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06036810

Recruiting

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

for
Low Grade Serous Ovarian Cancer
Location: New Haven CT, New York NY, Montreal, Philadelphia PA,
Sponsor: Verastem, Inc.

Sex: Female

Age: 18+

Code: NCT06072781

Phase3, Recruiting

A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers

for
Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma,
Location: Boston MA, Hackensack NJ, Buffalo NY, Pittsburgh PA,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT06469281

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

for
Brain Cancer, Breast Cancer, Bladder Cancer, Cervical Cancer,
Location: Miami FL, Florence SC, Charleston SC, Cleveland OH,
Sponsor: Adela, Inc

Sex: All

Age: 40+

Code: NCT05366881

Recruiting

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

for
Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer,
Location: Chicago IL
Sponsor: Northwestern University

Sex: Female

Age: 18 - 70+

Code: NCT00005095

Recruiting

A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

for
Ovarian Cancer, Solid Tumor
Location: Boston MA, New Haven CT, New York NY, Fairfax VA,
Sponsor: OnCusp Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06234423

Phase1, Recruiting

A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib

for
Endometrioid Cancer, Mucinous Ovarian Cancer,
Location: Orlando FL, New Orleans LA, Oklahoma City OK,
Sponsor: University of Oklahoma

Sex: Female

Age: 18 - 70+

Code: NCT05512208

Phase2, Recruiting

Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer

for
Ovarian Cancer, Fallopian Tube, Primary Peritoneal Cancer
Location: Richmond VA, Pittsburgh PA, Columbus OH, Birmingham AL,
Sponsor: University of Alabama at Birmingham

Sex: Female

Age: 18+

Code: NCT04606914

Phase2, Recruiting

HIPEC After Initial CRS in Patients Who Have Received NACT

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: New Hyde Park NY
Sponsor: Northwell Health

Sex: Female

Age: 18 - 70+

Code: NCT03540017

Phase1, Recruiting

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

for
Ovarian Cancer, Pancreas Cancer, Urothelial Carcinoma,
Location: New York NY, Rochester NY, Atlanta GA, Denver CO,
Sponsor: Nammi Therapeutics Inc

Sex: All

Age: 18+

Code: NCT06582017

Phase1, Recruiting

Combination Therapy for Recurrent Ovarian Cancer

for
Recurrent Ovarian Cancer
Location: Louisville KY
Sponsor: Sham Sunder Kakar

Sex: Female

Age: 18+

Code: NCT05610735

Phase1, Phase2, Recruiting

Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian Cancer

for
Ovarian Cancer, Stage III Ovarian Cancer,
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: Female

Age: 18+

Code: NCT05961124

Phase2, Recruiting

Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

for
Pancreatic Cancer, Renal Cell Cancer, Breast Cancer, Melanoma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT02830724

Phase1, Phase2, Recruiting

Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation

for
Ovarian Cancer
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 0 - 30

Code: NCT06518746

Recruiting

Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer

for
Breast Cancer, Cervical Cancer, Endometrial Cancer,
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston

Sex: Female

Age: 18+

Code: NCT00003135

Phase2, Recruiting

DOD Long-Term Survivors of Ovarian Cancer

for
Ovarian Cancer
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: Female

Age: 18 - 70+

Code: NCT02321735

Recruiting

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

for
Solid Tumor, Breast Cancer, Pancreatic Cancer, Ovarian Cancer,
Location: Huntersville NC, Detroit MI, Houston TX,
Sponsor: Qurgen Inc.

Sex: All

Age: 18+

Code: NCT05989724

Phase1, Recruiting

Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy

for
Ovarian Cancer, Ovarian Carcinoma, Ovarian Cancer Stage IV,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: Female

Age: 18+

Code: NCT04997096

Recruiting